Thumbs Up From FDA Panel for Sarcoma Drug

]]>(MedPage Today) -- WASHINGTON--A drug for a rare type of sarcoma received a unanimous recommendation for approval from an FDA advisory committee, despite risk-benefit doubts expressed by FDA staff.The Oncologic Drugs Advisory Committee (ODAC...